Identity and Access Management Software Provider BIO-key Reports Q1’24 Revenue of $2.2M and Positive Operating Cash Flow; Hosts Investor Call Tuesday, 10am ET
17 juin 2024 08h00 HE
|
BIO-key International, Inc.
Identity, Access Management Software Provider BIO-key Reports Q1’24 Revenue of $2.2M and Positive Operating Cash Flow; Hosts Investor Call Tuesday, 10am ET
Orion’s Q4’24 Revenue Rose 22% to $26.4M; FY’24 Revenue of $90.6M Driven by Growth Across LED Lighting, EV Charging and Maintenance Businesses; Targets FY 2025 Revenue Growth of 10-15%
06 juin 2024 07h29 HE
|
Orion Energy Systems, Inc.
Orion’s Q4’24 Revenue Rose 22% to $26.4M; FY’24 Revenue of $90.6M Driven by Growth Across LED Lighting, EV Charging and Maintenance Businesses.
LED Lighting, EV Charging and Maintenance Solutions Provider Orion Hosts Q4 Call Thurs., June 6th at 10am ET
30 mai 2024 16h13 HE
|
Orion Energy Systems, Inc.
LED Lighting, EV Charging and Maintenance Solutions Provider Orion Hosts Q4 Call Thurs., June 6th at 10am ET
Niu Technologies Announces Unaudited First Quarter 2024 Financial Results
20 mai 2024 03h00 HE
|
NIU Technologies
-- First Quarter Revenues of RMB 504.7 million, an increase of 21.0% year-over-year -- First Quarter Net Loss of RMB 54.8 million, compared to Net Loss of RMB 60.3 million in the same period of last...
Consolidated Water Reports First Quarter 2024 Revenue up 21% to $39.7 Million, Driving Net Income from Continuing Operations of $6.9 Million or $0.43 Diluted EPS
15 mai 2024 16h10 HE
|
Consolidated Water Co. Ltd.
GEORGE TOWN, Cayman Islands, May 15, 2024 (GLOBE NEWSWIRE) -- Consolidated Water Co. Ltd. (NASDAQ Global Select Market: CWCO), a leading designer, builder and operator of advanced water supply and...
Pacific Health Care Organization, Inc. Reports its First Quarter 2024 Results
13 mai 2024 20h22 HE
|
Pacific Health Care Organization, Inc.
Irvine, May 13, 2024 (GLOBE NEWSWIRE) -- Pacific Health Care Organization, Inc., (the “Company”) (OTCQB: PFHO) today filed with the Securities and Exchange Commission (the “Commission”) its...
Innospec Reports First Quarter 2024 Financial Results
09 mai 2024 16h45 HE
|
Innospec Inc.
Strong contribution from Performance Chemicals drives operating income growth of 23 percent $80.6 million cash generated from operations; Net cash improves to $270.1 million Dividend...
HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
09 mai 2024 16h05 HE
|
HilleVax, Inc.
Topline data from NEST-IN1 Phase 2B clinical study of HIL-214 in infants expected in mid-2024 $272.7 million of cash, cash equivalents and marketable securities as of March 31, 2024 BOSTON, May ...
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radiopharma Pipeline
09 mai 2024 07h00 HE
|
Monopar Therapeutics Inc.
Initiated MNPR-101-Zr First-in-Human Phase 1 Radiopharma Clinical Trial MNPR-101-RIT Phase 1 Clinical Trial Targeted for Launch as Early as Q4 2024 or Q1 2025 WILMETTE, Ill., May 09, 2024 (GLOBE...
Aveanna Healthcare Holdings Announces First Quarter 2024 Financial Results and Revised 2024 Outlook
09 mai 2024 06h30 HE
|
Aveanna Healthcare Holdings, Inc
First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 First Quarter Net loss was $11.2 million, compared to...